A

Adagene

ADAG

2.57000
USD
0.17
(7.08%)
مغلق
حجم التداول
13
الربح لكل سهم
0
العائد الربحي
0
P/E
-4
حجم السوق
132,812,352
الأخبار المقالات

العنوان: Adagene

القطاع: Healthcare
الصناعة: Biotechnology
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.